Delivery Order SPE2DB22D1103-SPE2DB25FTLM0
Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,017.78 by the Defense Logistics Agency on July 18, 2025, with an ultimate completion date of July 21, 2025. The delivery order, issued under a firm fixed-price contract type with no set-aside designation, covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in treating chronic obstructive pulmonary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for TRELEGY ELLIPTA 100-62.5-25 (60 count) by the Defense Logistics Agency on September 8, 2025. The award carries a ceiling value of $1,441.50 and represents a firm fixed price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. This child contract is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication used to treat chronic obstructive pulmonary disease. This competitive, non-set-aside contract was awarded on July 30, 2025, with a ceiling value of $1,383.71 and an ultimate completion date of July 31, 2025. The delivery order will be performed at the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count). This competitively awarded, firm fixed-price delivery order is valued at $64,211.41 with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is...
- AmerisourceBergen Drug Corp received a delivery order contract valued at $37,479.45 from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. The contract was completed on August 22, 2025, with performance...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,237.76 for TRELEGY ELLP 200MC 60S, a respiratory maintenance medication, on September 19, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of September 22, 2025. The order will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and is funded through the Defense Logistics Agency's Medical Supply Chain,...
- AmerisourceBergen Drug Corp received a delivery order valued at $1,513.12 from the Defense Logistics Agency (DLA) on August 7, 2025, for Trelegy Ellipta 200-62.5-25, a combination respiratory medication used in treating chronic obstructive pulmonary disease. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. This delivery order is performed at the company's corporate office location...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $10,154.64 for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used primarily for chronic obstructive pulmonary disease management. Awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed price delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $98,086.77 for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract vehicle with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...